Sparking Drug Discovery Efficiency with CRISPR-Cas9
The CRISPR-Cas system, supported by advances in plate reader technology, has transformed drug discovery processes.
The speed, targeting flexibility, and ease-of-use of the CRISPR-Cas system gives researchers the capability to create relevant experimental models for drug discovery screening and testing. To avoid creating bottlenecks, data acquisition and analysis must keep pace with this boom in model generation. Highly sensitive multimode plate readers support CRISPR-Cas applications such as compound screening and clonal selection.
Download this white paper from Tecan to learn how plate reader technology and CRISPR-Cas systems create a formidable combination for drug discovery research.
